You are viewing: Europe POP Treatment and Management / Pelvic Organ Prolapse Market analysis

The Europe POP Treatment and Management / Pelvic Organ Prolapse Market was valued at $24.86 Million in 2025 and projected to reach to $34.09 Million by 2030, representing a compound annual growth rate of 6.5%. Europe's pelvic organ prolapse market demonstrates consistent growth momentum driven by an aging population and heightened clinical awareness.

Europe POP Treatment and Management / Pelvic Organ Prolapse Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe POP Treatment and Management / Pelvic Organ Prolapse Market Trends and Insights

  • This steady expansion in Europe reflects increasing awareness of POP among healthcare providers and patients, coupled with an aging demographic that drives higher prevalence rates across the region.
  • Europe's well-established healthcare infrastructure and reimbursement frameworks support adoption of both conservative and surgical treatment modalities. The European market benefits from robust clinical research initiatives and regulatory support for innovative POP management solutions.
  • Europe's diverse healthcare systems—spanning public and private sectors—create varied market dynamics across countries, with Northern and Western European nations leading in treatment adoption rates.
  • Between 2025 and 2030, Europe is expected to see accelerated investment in minimally invasive surgical techniques and pelvic floor rehabilitation programs, positioning the region as a key growth driver within the global POP market..

Key Market Statistics

  • CAGR (2025-2030) 6.5% CAGR
  • Market Size, 2025 ~USD 24.86 Million
  • Forecast, 2030 ~USD 34.09 Million
  • Geography Europe

Europe POP Treatment and Management / Pelvic Organ Prolapse Market Overview

Market Valuation & Growth :

Europe's POP treatment and management market is valued at $24.86 million in 2025, with a projected growth to $34.09 million by 2030, representing a steady 6.5% CAGR aligned with global expansion trends.

Aging Population Driver :

Europe's aging demographic significantly increases pelvic organ prolapse prevalence, particularly among postmenopausal women, creating sustained demand for innovative treatment and management solutions across the region.

Healthcare Provider Awareness :

Increasing awareness among European healthcare providers and gynecologists regarding POP diagnosis and treatment options is driving market adoption and improving patient outcomes across clinical settings.

Regional Market Leadership :

Germany, France, and the UK lead Europe's market with combined market sizes exceeding $35 million, reflecting advanced healthcare infrastructure and higher accessibility to POP treatment modalities.

Europe POP Treatment and Management / Pelvic Organ Prolapse Market Dynamics

  • The region benefits from well-established healthcare systems, robust reimbursement frameworks, and increasing patient education initiatives that support market expansion through 2030. Key growth catalysts include rising prevalence rates among elderly women, technological advancements in minimally invasive treatment options, and expanding access to specialized gynecological care.
  • European healthcare providers are increasingly adopting comprehensive POP management protocols, positioning the region for sustained 6.5% annual growth as demand for both conservative and surgical interventions continues to rise..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Europe's POP market is valued at $24.86 million in 2025 and will reach $34.09 million by 2030, growing at a 6.5% CAGR.
    • Europe's aging population and improved healthcare awareness are primary drivers of POP diagnosis and treatment uptake across the region.
    • Minimally invasive surgical techniques and pelvic floor physical therapy are gaining traction in Europe's treatment landscape.
    • Europe's diverse healthcare systems create regional variations, with Western and Northern European markets leading in innovation adoption.

    POP Treatment and Management / Pelvic Organ Prolapse Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment SACROCOLPOPEXY (Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6.6% from 2025 to 2030
    Largest Segment SURGICAL (Treatment)
    Market Size Base Year (Billions) ~USD 0.77 (2025)
    Revenue Forecast (Billions) ~USD 1.06 (2030)
    Segments Covered Product, Treatment, Type, Application, End User

    Europe POP Treatment and Management / Pelvic Organ Prolapse Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product

    • Biological Grafts
    • Diagnostic & Assessment Tools
    • Pelvic Floor Therapy Devices
    • Robotic Surgery Systems
    • Sutures
    • Synthetic Mesh
    • Vaginal Pessaries

    By Treatment

    • Non-Surgical
    • Surgical

    By Type

    • Colpocleisis
    • Colporrhaphy
    • Pelvic Floor Muscle Therapy
    • Sacrocolpopexy
    • Sacrohysteropexy
    • Uterosacral Or Sacrospinous Ligament Fixation
    • Vaginal Pessary Management

    By Application

    • Cystocele
    • Enterocele
    • Rectocele
    • Urethrocele
    • Uterine Prolapse

    By End User

    • Ambulatory Surgery Centers
    • Hospitals
    • Other End Users
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : Require detailed European market data to assess market size, growth potential, and regional variations for POP treatment devices, guiding product development and market expansion strategies across key European markets.
    • Pharmaceutical Companies : Need comprehensive insights into European treatment protocols, patient populations, and clinical adoption patterns to inform drug development pipelines and commercialization strategies for POP management therapies.
    • Healthcare Providers & Hospitals : Utilize market intelligence to understand treatment demand trends, patient demographics, and emerging care modalities to optimize service offerings and resource planning for gynecological departments.
    • Investment & Private Equity Firms : Require market valuation data, growth forecasts, and regional opportunity analysis to evaluate investment potential in European POP treatment companies and healthcare technology ventures.
    • Healthcare Consultants & Analysts : Need authoritative European market data and forecasts to support client advisory services, competitive benchmarking, and strategic planning initiatives in the women's health and gynecological care sectors.

    Key Companies in the Europe POP Treatment and Management / Pelvic Organ Prolapse Market

    CompanyHQOwnershipStrongest segments
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (CRM, structural heart, peripheral interventions, LAAC),MedSurg Endoscopy (GI, pancreaticobiliary, single-use scopes, infection prevention),Urology and Pelvic Health,
    COOPERCOMPANIESUnited StatesPublic CompanySpherical contact lenses,Toric and multifocal contact lenses,Fertility consumables, equipment, and services,
    JOHNSON & JOHNSONUnited StatesPublic CompanyOncology,Immunology,Neuroscience and Other Innovative Medicine,
    GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
    INTEGRA LIFESCIENCES CORPORATIONUnited StatesPublic CompanyNeurosurgery & Neurocritical Care (Codman Specialty Surgical),ENT, Navigation & Surgical Instrumentation,Tissue Technologies – Wound, Skin & Reconstruction,
    FEG TEXTILTECHNIK FORSCHUNGS- UND ENTWICKLUNGSGESELLSCHAFT MBHGermanyPrivate CompanyContract R&D and prototyping,Process engineering and scale-up services,Consulting, testing, and training,

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a publicly traded medical device company founded in 1979 and headquartered in the United States. With 59,000 employees, the company develops and manufactures a broad range of medical devices and technologies for various healthcare applications.

    COOPERCOMPANIES

    Cooper Companies is a publicly traded medical device company founded in 1958 and headquartered in the United States. With 15,000 employees, the company operates in the contact lens and eye care markets.

    JOHNSON & JOHNSON

    Johnson & Johnson is a publicly traded multinational healthcare company founded in 1886 and based in the United States. With 138,200 employees, the company operates across pharmaceuticals, medical devices, and consumer health segments.

    GE HEALTHCARE

    GE Healthcare is a publicly traded medical technology company founded in 2022 and headquartered in the United States. The company employs 54,000 people and provides healthcare imaging, monitoring, and diagnostic solutions.

    INTEGRA LIFESCIENCES CORPORATION

    Integra LifeSciences Corporation is a publicly traded medical device company founded in 1989 and based in the United States. With 4,427 employees, the company develops and manufactures surgical instruments and regenerative medicine products.

    FEG TEXTILTECHNIK FORSCHUNGS- UND ENTWICKLUNGSGESELLSCHAFT MBH

    FEG Textiltechnik Forschungs- und Entwicklungsgesellschaft mbH is a privately held company founded in 1991 and headquartered in Germany. The company specializes in textile technology research and development.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 47.06 Million · 3.5% wtd CAGR ·
    Asia Pacific
    ~USD 19.72 Million · 7.3% wtd CAGR ·
    Latin America
    ~USD 7.37 Million · 4.3% wtd CAGR ·
    Middle East & Africa
    ~USD 2.22 Million · 4.6% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 13495 Million
    FranceUSD 11846 Million
    UKUSD 10491 Million
    ItalyUSD 6403 Million
    SpainUSD 5256 Million
    Rest Of EuropeUSD 8.6 Million

    Country market size visualization

    Germany
    USD 13495 Million
    France
    USD 11846 Million
    UK
    USD 10491 Million
    Italy
    USD 6403 Million
    Spain
    USD 5256 Million
    Rest Of Europe
    USD 8.6 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into Europe's five largest markets (Germany, France, UK, Italy, Spain) with country-specific market sizes, growth trajectories, and competitive landscapes essential for targeted market entry strategies.
    • Demographic & Clinical Insights : Understand Europe's aging population dynamics and their direct correlation to POP prevalence rates, enabling accurate demand forecasting and product development aligned with regional patient demographics.
    • Healthcare System Analysis : Access comprehensive data on European healthcare infrastructure, reimbursement policies, and clinical practice patterns that influence treatment adoption rates and market opportunities across different healthcare systems.
    • Competitive Positioning : Identify leading treatment modalities, key market players, and emerging technologies gaining traction in Europe's POP market to inform competitive strategy and partnership opportunities.
    • Growth Forecasting Through 2030 : Leverage detailed 5-year projections and CAGR analysis to support investment decisions, resource allocation, and long-term business planning in Europe's expanding pelvic organ prolapse treatment sector.

    Frequently asked questions

    What is the current market size of POP treatment in Europe?

    Europe's POP treatment and management market is valued at $24.86 million in 2025 and is expected to grow to $34.09 million by 2030.

    What is the projected growth rate for Europe's POP market?

    Europe's POP market is projected to grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2030.

    What factors are driving growth in Europe's POP market?

    Key drivers include Europe's aging population, increased healthcare awareness, robust reimbursement frameworks, and growing adoption of minimally invasive treatment options.

    Which European regions are leading in POP treatment adoption?

    Western and Northern European nations are leading in POP treatment adoption, driven by advanced healthcare infrastructure and higher healthcare spending.

    What treatment modalities are most prevalent in Europe?

    Europe's POP market encompasses conservative management (pelvic floor physical therapy), surgical interventions, and increasingly, minimally invasive surgical techniques.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the POP Treatment and Management / Pelvic Organ Prolapse market. Exhaustive secondary research was done to collect information on the POP Treatment and Management / Pelvic Organ Prolapse industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the POP Treatment and Management / Pelvic Organ Prolapse market.

    The four steps involved in estimating the market size are:

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS)] to identify and collect information for the global POP Treatment and Management / Pelvic Organ Prolapse market study. Secondary sources were also used to obtain important information about the key players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the POP Treatment and Management / Pelvic Organ Prolapse market. The primary sources from the demand side included pharmaceutical companies, biotechnology companies, CROs, medical device companies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

    The following is a breakdown of the primary respondents:

    POP Treatment and Management / Pelvic Organ Prolapse Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global POP Treatment and Management / Pelvic Organ Prolapse market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. The global POP Treatment and Management / Pelvic Organ Prolapse market was split into various segments and sub-segments based on:

    • List of major players operating in the products market at the regional and/or country level
    • Product mapping of POP Treatment and Management / Pelvic Organ Prolapse providers at the regional and/or country level
    • Mapping of annual revenue generated by listed major players from POP Treatment and Management / Pelvic Organ Prolapse (or the nearest reported business unit/product category)
    • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
    • Summation of the market value of all segments/subsegments to arrive at the global POP Treatment and Management / Pelvic Organ Prolapse market
    • The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

    The research methodology used to estimate the market size includes the following:

    POP Treatment and Management / Pelvic Organ Prolapse Market

    Data Triangulation

    After arriving at the overall market size by applying the processes mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Pelvic organ prolapse (POP) is a condition in which the pelvic organs—such as the vagina, uterus, bladder, or rectum—descend from their normal anatomical positions. This occurs when the pelvic floor, composed of muscles, ligaments, and connective tissues that provide structural support to these organs, is weakened or stretched. The pelvic floor functions as a supportive structure beneath the pelvic organs. When these supportive structures lose strength or elasticity, the organs may shift out of place or protrude into the vaginal canal. Common causes of pelvic floor weakening include childbirth, aging, and other factors that increase intra-abdominal pressure.

    Stakeholders

    • Pelvic Organ Prolapse Product Manufacturers
    • Research and Consulting Firms
    • Distributors of Pelvic Organ Prolapse Devices
    • Private Insurance Companies
    • Gynecologists and Urogynecologists
    • Healthcare Institutes (Hospitals, Medical Schools, Diagnostic Centers, and Outpatient Clinics)
    • Research Institutes
    • Venture Capitalists

    Report Objectives

    • To define, describe, segment, and forecast the global POP Treatment and Management / Pelvic Organ Prolapse market by product, treatment, application, end user, and region
    • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall POP Treatment and Management / Pelvic Organ Prolapse market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To benchmark players within the market using the proprietary company evaluation matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
    • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

    Get the Full POP Treatment and Management / Pelvic Organ Prolapse Market Report

    Full forecast, segment splits, and company analysis for all POP Treatment and Management / Pelvic Organ Prolapse Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status